MERSANA THERAPEUTICS
Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. It was founded in 2005 and headquartered in Cambridge, Massachusetts.
MERSANA THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2005-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.mersana.com
Total Employee:
101+
Status:
Active
Contact:
617-498-0020
Email Addresses:
[email protected]
Total Funding:
480.61 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Protagonist Therapeutics
Protagonist Therapeutics develops orally-stable peptides to treat diseases that are currently addressed by injectable antibodies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Mersana Therapeutics
Consonance Capital Partners
Consonance Capital Partners investment in Post-IPO Equity - Mersana Therapeutics
Avoro Capital Advisors
Avoro Capital Advisors investment in Post-IPO Equity - Mersana Therapeutics
ArrowMark Partners
ArrowMark Partners investment in Series C - Mersana Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Mersana Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Series C - Mersana Therapeutics
Wellington Management
Wellington Management investment in Series C - Mersana Therapeutics
New Enterprise Associates
New Enterprise Associates investment in Series C - Mersana Therapeutics
Takeda
Takeda investment in Series C - Mersana Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Mersana Therapeutics
Key Employee Changes
Official Site Inspections
http://www.mersana.com Semrush global rank: 6.43 M Semrush visits lastest month: 1.02 K
- Host name: 104.136.227.35.bc.googleusercontent.com
- IP address: 35.227.136.104
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043